Personal Lab Offers Rapid Detection of Food Allergens
|
By LabMedica International staff writers Posted on 06 Nov 2017 |

Image: The iEAT system for onsite antigen detection consists of a pocket-sized detector, an electrode chip, and a disposable kit for allergen extraction. The detector connects with a smartphone for system control and data upload to a cloud server (Photo courtesy of Lin, et al. ACS Nano, August 2017).
Researchers have developed a small, low cost device for individual use that can accurately detect food allergens in less than ten minutes.
Adverse food reactions, including food allergies, food sensitivities, and autoimmune reaction (e.g., celiac disease) affect 5-15% of the population of the USA and remain a considerable public health problem requiring stringent food avoidance and epinephrine availability for emergency events. Avoiding problematic foods is difficult in practical terms, given current reliance on prepared foods and out-of-home meals.
In response to the food allergy problem, investigators at Harvard Medical School (Boston, MA, USA) developed a portable, point-of-use detection technology, that they called "integrated exogenous antigen testing" (iEAT).
The iEAT device consists of three components: (1) a small plastic test tube, (2) a small electronic detection module, and (3) the electronic keychain reader. To perform the test, the user dissolves a small sample of the food in the plastic test tube and then adds magnetic beads that capture the food allergen of interest. A bit of this mixture is loaded onto electrode strips attached to a small module that is then inserted into the electronic keychain reader. The keychain reader has a small display that indicates whether the allergen is present, and if so, in what concentration.
The prototype iEAT system was optimized to detect five major food antigens in peanuts, hazelnuts, wheat, milk, and eggs. Antigen extraction and detection with iEAT required less than 10 minutes and achieved high-detection sensitivities (e.g., 0.1 milligram per kilogram for gluten, 200 times lower than regulatory limits of 20 milligram per kilogram).
The investigators also developed a dedicated cell phone application, which allows the user to compile and store the data collected by testing different foods for various allergens at different restaurants or in packaged foods. The application is set up to share this information online with both time and location stamps indicating when, where, and in what food or dish an allergen reading was taken.
“High accuracy built into a compact system was the key goals of the project,” said contributing author Dr. Ralph Weissleder, professor of radiology and systems biology at Harvard Medical School. “Users can be confident that even if they are sensitive to very low levels, iEAT will be able to give them exact concentrations. Armed with accurate concentration levels they will not have to completely avoid potentially problematic foods, but will know whether an allergen is at a dangerous level for them or a concentration that is safe for them to eat.”
The iEAT device was described in the August 2017 issue of the journal ACS Nano.
Related Links:
Harvard Medical School
Adverse food reactions, including food allergies, food sensitivities, and autoimmune reaction (e.g., celiac disease) affect 5-15% of the population of the USA and remain a considerable public health problem requiring stringent food avoidance and epinephrine availability for emergency events. Avoiding problematic foods is difficult in practical terms, given current reliance on prepared foods and out-of-home meals.
In response to the food allergy problem, investigators at Harvard Medical School (Boston, MA, USA) developed a portable, point-of-use detection technology, that they called "integrated exogenous antigen testing" (iEAT).
The iEAT device consists of three components: (1) a small plastic test tube, (2) a small electronic detection module, and (3) the electronic keychain reader. To perform the test, the user dissolves a small sample of the food in the plastic test tube and then adds magnetic beads that capture the food allergen of interest. A bit of this mixture is loaded onto electrode strips attached to a small module that is then inserted into the electronic keychain reader. The keychain reader has a small display that indicates whether the allergen is present, and if so, in what concentration.
The prototype iEAT system was optimized to detect five major food antigens in peanuts, hazelnuts, wheat, milk, and eggs. Antigen extraction and detection with iEAT required less than 10 minutes and achieved high-detection sensitivities (e.g., 0.1 milligram per kilogram for gluten, 200 times lower than regulatory limits of 20 milligram per kilogram).
The investigators also developed a dedicated cell phone application, which allows the user to compile and store the data collected by testing different foods for various allergens at different restaurants or in packaged foods. The application is set up to share this information online with both time and location stamps indicating when, where, and in what food or dish an allergen reading was taken.
“High accuracy built into a compact system was the key goals of the project,” said contributing author Dr. Ralph Weissleder, professor of radiology and systems biology at Harvard Medical School. “Users can be confident that even if they are sensitive to very low levels, iEAT will be able to give them exact concentrations. Armed with accurate concentration levels they will not have to completely avoid potentially problematic foods, but will know whether an allergen is at a dangerous level for them or a concentration that is safe for them to eat.”
The iEAT device was described in the August 2017 issue of the journal ACS Nano.
Related Links:
Harvard Medical School
Latest Technology News
- Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows
- New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows
- Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
- Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
- New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs
- ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
- Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions
- New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling
- Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins
- Autonomous Robotic System Receives FDA Authorization for Blood Collection
- Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
- Training Device Improves Accuracy of Pooled Molecular Diagnostics
- New CE-Certified Software Advances Whole-Genome Cancer Testing
- National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
Channels
Clinical Chemistry
view channel
Blood Proteins Linked to Mortality Risk and Biological Aging Across Organ Systems
Older adults of the same chronological age can differ markedly in health, chronic disease burden, and resilience. Biological age aims to capture these differences by reflecting how rapidly the body and... Read more
Two-Step Blood Test Improves Specificity for Alzheimer’s Diagnosis
Early Alzheimer’s disease can be difficult to identify before more severe cognitive symptoms emerge. Blood tests measuring phosphorylated tau protein p-tau217 may help detect disease-related changes, but... Read moreHematology
view channel
New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL
Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read moreImmunology
view channel
COVID-19 and Flu Combo Test Launches With FDA Clearance
Overlapping symptoms of COVID-19 and influenza can create diagnostic uncertainty, particularly in urgent and point-of-care settings. Rapid differentiation from a single specimen can streamline triage and... Read more
Compact Immunoanalyzer Gains CE Mark for Testing Across Local Care Settings
Smaller clinics and laboratories must deliver reliable results despite limited infrastructure, outsourcing delays, and workforce shortages. These pressures highlight the need for consistent immunoassay... Read moreMicrobiology
view channel
Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea
Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more
Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read morePathology
view channel
Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer
In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more
AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer
High-grade serous tubo-ovarian carcinoma is an aggressive cancer arising in the ovaries or fallopian tubes. Some tumors exhibit homologous recombination deficiency (HRD), a feature reflecting impaired DNA repair.... Read moreTechnology
view channel
Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows
Molecular laboratories rely on nucleic acid analysis to detect molecular information accurately and reproducibly across a wide range of applications. Supporting these routine workflows, a newly launched... Read more
New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows
Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read moreIndustry
view channel
Collaboration Brings Tumor-Informed MRD Monitoring to Breast Cancer Care in Abu Dhabi
For many patients, cancer treatment does not eliminate the risk of recurrence, which may occur months or years later and become harder to treat after spreading. Recurrence is often detected only after... Read more







